院外心脏骤停幸存者的长期临床结局与死亡预测因素
该研究为基于人群的队列研究,链接Toronto RescuNET心脏骤停数据库与加拿大安大略省行政数据库,纳入2005年12月1日至2014年12月31日非创伤性院外心脏骤停患者。在28,611例现场接受治疗的患者中,1,591例存活至出院。出院后1年12.6%死亡、37.3%再入院;3年死亡率为20%、全因再入院率54.1%。高龄和癌症病史与3年死亡风险升高相关;可电击心律(HR 0.62,95%CI 0.45-0.85)、冠脉血运重建(HR 0.37,95%CI 0.28-0.51)和植入ICD(HR 0.28,95%CI 0.20-0.41)与3年死亡率显著降低相关。作者认为需要临床试验评估有创心脏操作对OHCA幸存者的潜在获益。
要点
- 28,611例现场治疗的OHCA患者中1,591例存活至出院,出院后1年死亡率12.6%、3年死亡率20%。
- 出院后1年再入院率37.3%,3年全因再入院率54.1%。
- 可电击心律与3年死亡率降低相关(HR 0.62,95%CI 0.45-0.85)。
- 冠脉血运重建(HR 0.37,95%CI 0.28-0.51)和植入ICD(HR 0.28,95%CI 0.20-0.41)与3年死亡率降低相关。
- 高龄和癌症病史与3年死亡风险升高相关;既往心脏病史和其他骤停特征与长期死亡率无关。
适用人群与场景
- 2005年12月1日至2014年12月31日期间,加拿大安大略省非创伤性院外心脏骤停且在现场接受治疗的患者。
- 分析对象为存活至出院的OHCA患者。
研究设计与关键结果
- 研究类型:基于人群的队列研究,链接Toronto RescuNET心脏骤停数据库与加拿大安大略省行政数据库。
- 样本量:28,611例现场接受治疗的OHCA患者,其中1,591例存活至出院。
- 住院期间:36%接受冠脉血运重建,27%接受植入式心律转复除颤器(ICD)。
- 出院后1年:12.6%死亡,37.3%再入院。
- 出院后3年:死亡率为20%,全因再入院率为54.1%。
- 3年死亡率预测因素:高龄和癌症病史与 higher risk 相关;可电击心律(HR 0.62,95%CI 0.45-0.85)、冠脉血运重建(HR 0.37,95%CI 0.28-0.51)、植入ICD(HR 0.28,95%CI 0.20-0.41)与 substantially lower 3年死亡率相关。
- 既往心脏病史和其他骤停特征与长期死亡率无关。
证据类型、等级与局限
- 证据类型:基于人群的队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为:需要临床试验评估有创心脏操作对OHCA幸存者的潜在获益。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
AIMS: Improvement in resuscitation efforts has translated to an increasing number of survivors after out-of-hospital cardiac arrest (OHCA). Our objectives were to assess the long-term outcomes and predictors of mortality for patients who survived OHCA.
METHODS: We conducted a population-based cohort study linking the Toronto RescuNET cardiac arrest database with administrative databases in Ontario, Canada. We included patients with non-traumatic OHCA from December 1, 2005 to December 31, 2014. The primary outcomes were mortality at 1 year and 3 years. Cox proportional hazard models were constructed to evaluate the predictors of mortality.
RESULTS: Among the 28,611 OHCA patients who received treatment at the scene of arrest, 1591 patients survived to hospital discharge. During hospitalization, 36% received coronary revascularizations and 27% received an implantable cardioverter defibrillator. At one year after discharge, 12.6% of patients had died and 37.3% were readmitted. At 3 years, mortality rate was 20% and all-cause readmission rate was 54.1%. Older age and a history of cancer were associated with higher risk of 3-year mortality. Shockable rhythm at presentation (hazard ratio [HR] 0.62, 95% CI 0.45-0.85), use of coronary revascularization (HR 0.37, 95% CI 0.28-0.51) or implantable cardioverter defibrillator (HR 0.28, 95% CI 0.20-0.41) was associated with substantially lower 3-year mortality. Prior cardiac conditions and other arrest characteristics were not associated with long-term mortality.
CONCLUSIONS: Survivors of OHCA face significant morbidity and mortality after hospital discharge. Clinical trials are needed to evaluate the potential benefits of invasive cardiac procedures in OHCA survivors.
参考来源
- Shuvy M, Morrison LJ, Koh M, et al. Long-term clinical outcomes and predictors for survivors of out-of-hospital cardiac arrest. Resuscitation. 2017. PMID: 28104428. doi:10.1016/j.resuscitation.2016.12.026
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。